Jeffrey A Gilreath (Jeffrey Gilreath)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Drug Administration

Chemotherapy Induced

Top Venues

Journal of blood medicine

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

George M Rodgers, Misa Berndt, Megan Fonteno, Jeffrey A Gilreath
Prolonged Exposure to Caplacizumab as Rescue Therapy in Refractory Immune Thrombotic Thrombocytopenic Purpura. Journal of blood medicine 14 (2023)
George M Rodgers, Misa Berndt, Megan Fonteno, Jeffrey A Gilreath
Prolonged Exposure to Caplacizumab as Rescue Therapy in Refractory Immune Thrombotic Thrombocytopenic Purpura. Journal of blood medicine 14 (2023)
Jeffrey A Gilreath, Mimi Lo, Joseph Bubalo
Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists. Drugs 81 (11) (2021)
Tamta Makharadze, Ralph Boccia, Anna Krupa, Nicole Blackman, David H Henry, Jeffrey A Gilreath
Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, placebo-controlled study (IRON-CLAD). American journal of hematology 96 (12) (2021)